{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T18:46:38Z","timestamp":1772304398379,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,28]],"date-time":"2022-09-28T00:00:00Z","timestamp":1664323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,28]],"date-time":"2022-09-28T00:00:00Z","timestamp":1664323200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>There are currently no scoring-type predictive models using only easily available pre- and intraoperative data developed for assessment of the risk of advanced axillary lymph node metastasis (ALNM) in patients with breast cancer with metastatic sentinel lymph nodes (SLNs). We aimed to develop and validate a scoring system using only pre- and intraoperative data to distinguish between non-advanced (\u2264 3 lymph nodes) and advanced (&gt; 3 lymph nodes) ALNM in patients with breast cancer with metastatic SLNs.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We retrospectively identified 804 patients with breast cancer (cT1-3cN0) who had metastatic SLNs and had undergone axillary lymph node dissection (ALND). We evaluated the risk factors for advanced ALNM using logistic regression analysis and developed and validated a scoring system for the prediction of ALNM using training (<jats:italic>n<\/jats:italic> = 501) and validation (<jats:italic>n<\/jats:italic> = 303) cohorts, respectively. The predictive performance was assessed using the receiver operating characteristic (ROC) curve, area under the curve (AUC), and calibration plots.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Ultrasound findings of multiple suspicious lymph nodes, SLN macrometastasis, the ratio of metastatic SLNs to the total number of SLNs removed, and the number of metastatic SLNs were significant risk factors for advanced ALNM. Clinical tumor size and invasive lobular carcinoma were of borderline significance. The scoring system based on these six variables yielded high AUCs (0.90 [training] and 0.89 [validation]). The calibration plots of frequency compared to the predicted probability showed slopes of 1.00 (training) and 0.85 (validation), with goodness-of-fit for the model. When the cutoff score was set at 4, the negative predictive values (NPVs) of excluding patients with advanced ALNM were 96.8% (training) and 96.9% (validation). The AUC for predicting advanced ALNM using our scoring system was significantly higher than that predicted by a single independent predictor, such as the number of positive SLNs or the proportion of positive SLNs. Similarly, our scoring system also showed good discrimination and calibration ability when the analysis was restricted to patients with one or two SLN metastases.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Our easy-to-use scoring system can exclude advanced ALNM with high NPVs. It may contribute to reducing the risk of undertreatment with adjuvant therapies in patients with metastatic SLNs, even if ALND is omitted.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12957-022-02779-9","type":"journal-article","created":{"date-parts":[[2022,9,28]],"date-time":"2022-09-28T05:02:46Z","timestamp":1664341366000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Development and validation of a pre- and intra-operative scoring system that distinguishes between non-advanced and advanced axillary lymph node metastasis in breast cancer with positive sentinel lymph nodes: a retrospective study"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0942-7599","authenticated-orcid":false,"given":"Takeshi","family":"Murata","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chikashi","family":"Watase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sho","family":"Shiino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arisa","family":"Kurita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayumi","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenjiro","family":"Jimbo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eriko","family":"Iwamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin","family":"Takayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiko","family":"Suto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,9,28]]},"reference":[{"key":"2779_CR1","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1001\/jama.2011.90","volume":"305","author":"AE Giuliano","year":"2011","unstructured":"Giuliano AE, Hunt KK, Ballman KV, Beitsch PD, Whitworth PW, Blumencranz PW, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA. 2011;305:569\u201375.","journal-title":"JAMA."},{"key":"2779_CR2","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/S1470-2045(14)70460-7","volume":"15","author":"M Donker","year":"2014","unstructured":"Donker M, van Tienhoven G, Straver ME, Meijnen P, van de Velde CJ, Mansel RE, et al. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981\u201322023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial. Lancet Oncol. 2014;15:1303\u201310.","journal-title":"Lancet Oncol."},{"key":"2779_CR3","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S1470-2045(13)70035-4","volume":"14","author":"V Galimberti","year":"2013","unstructured":"Galimberti V, Cole BF, Zurrida S, Viale G, Luini A, Veronesi P, et al. Trial 23-01 investigators. Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23\u201301): a phase 3 randomised controlled trial. Lancet Oncol. 2013;14:297\u2013305.","journal-title":"Lancet Oncol."},{"key":"2779_CR4","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1093\/annonc\/mdz235","volume":"30","author":"HJ Burstein","year":"2019","unstructured":"Burstein HJ, Curigliano G, Loibl S, Dubsky P, Gnant M, Poortmans P, et al. Estimating the benefits of therapy for early-stage breast cancer: the St. Gallen International Consensus Guidelines for the primary therapy of early breast cancer 2019. Ann Oncol. 2019;30:1541\u201357.","journal-title":"Ann Oncol."},{"key":"2779_CR5","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.breast.2020.08.001","volume":"53","author":"Z Yang","year":"2020","unstructured":"Yang Z, Lan X, Huang Z, Yang Y, Tang Y, Jing H, et al. Development and external validation of a nomogram to predict four or more positive nodes in breast cancer patients with one to three positive sentinel lymph nodes. Breast. 2020;53:143\u201351.","journal-title":"Breast."},{"key":"2779_CR6","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1245\/s10434-006-9107-8","volume":"14","author":"AB Chagpar","year":"2007","unstructured":"Chagpar AB, Scoggins CR, Martin RC 2nd, Cook EF, McCurry T, Mizuguchi N, et al. Predicting patients at low probability of requiring postmastectomy radiation therapy. Ann Surg Oncol. 2007;14:670\u20137.","journal-title":"Ann Surg Oncol."},{"key":"2779_CR7","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1200\/JCO.2007.11.9479","volume":"26","author":"A Katz","year":"2008","unstructured":"Katz A, Smith BL, Golshan M, Niemierko A, Kobayashi W, Raad RA, et al. Nomogram for the prediction of having four or more involved nodes for sentinel lymph node-positive breast cancer. J Clin Oncol. 2008;26:2093\u20138.","journal-title":"J Clin Oncol."},{"key":"2779_CR8","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/j.ijrobp.2008.12.028","volume":"75","author":"B Unal","year":"2009","unstructured":"Unal B, Gur AS, Beriwal S, Tang G, Johnson R, Ahrendt G, et al. Predicting likelihood of having four or more positive nodes in patient with sentinel lymph node-positive breast cancer: a nomogram validation study. Int J Radiat Oncol Biol Phys. 2009;75:1035\u201340.","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"2779_CR9","doi-asserted-by":"publisher","first-page":"270","DOI":"10.4048\/jbc.2017.20.3.270","volume":"20","author":"I Kim","year":"2017","unstructured":"Kim I, Ryu JM, Kim JM, Choi HJ, Lee SK, Yu JH, et al. Development of a nomogram to predict N2 or N3 stage in T1-2 invasive breast cancer patients with no palpable lymphadenopathy. J Breast Cancer. 2017;20:270\u20138.","journal-title":"J Breast Cancer."},{"key":"2779_CR10","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.ejso.2019.10.040","volume":"46","author":"K Jimbo","year":"2020","unstructured":"Jimbo K, Kinoshita T, Ogura T, Watase C, Murata T, Shiino S, et al. Prediction score model for non-sentinel and four or more nodal metastases using a combined method of one-step nucleic acid amplification and histology in sentinel node-positive breast cancer patients. Eur J Surg Oncol. 2020;46:516\u201321.","journal-title":"Eur J Surg Oncol."},{"key":"2779_CR11","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1245\/s10434-018-6633-0","volume":"25","author":"K Shimazu","year":"2018","unstructured":"Shimazu K, Sato N, Ogiya A, Sota Y, Yotsumoto D, Ishikawa T, et al. Intraoperative nomograms, based on one-step nucleic acid amplification, for prediction of non-sentinel node metastasis and four or more axillary node metastases in breast cancer patients with sentinel node metastasis. Ann Surg Oncol. 2018;25:2603\u201311.","journal-title":"Ann Surg Oncol."},{"key":"2779_CR12","doi-asserted-by":"publisher","first-page":"e302","DOI":"10.1016\/j.clbc.2020.11.008","volume":"21","author":"T Murata","year":"2021","unstructured":"Murata T, Watase C, Shiino S, Jimbo K, Iwamoto E, Yoshida M, et al. Development and validation of a preoperative scoring system to distinguish between nonadvanced and advanced axillary lymph node metastasis in patients with early-stage breast cancer. Clin Breast Cancer. 2021;21:e302\u201311.","journal-title":"Clin Breast Cancer."},{"key":"2779_CR13","doi-asserted-by":"publisher","first-page":"3004","DOI":"10.1245\/s10434-017-5935-y","volume":"24","author":"CK Harris","year":"2017","unstructured":"Harris CK, Tran HT, Lee K, Mylander C, Pack D, Rosman M, et al. Positive ultrasound-guided lymph node needle biopsy in breast cancer may not mandate axillary lymph node dissection. Ann Surg Oncol. 2017;24:3004\u201310. https:\/\/doi.org\/10.1245\/s10434-017-5935-y.","journal-title":"Ann Surg Oncol."},{"key":"2779_CR14","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.ejso.2018.04.003","volume":"44","author":"GH Lim","year":"2018","unstructured":"Lim GH, Upadhyaya VS, Acosta HA, Lim JMA, Allen JC, Leong LCH. Preoperative predictors of high and low axillary nodal burden in Z0011 eligible breast cancer patients with a positive lymph node needle biopsy result. Eur J Surg Oncol. 2018;44:945\u201350.","journal-title":"Eur J Surg Oncol."},{"key":"2779_CR15","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s10549-020-06047-w","volume":"185","author":"K Schumacher","year":"2021","unstructured":"Schumacher K, Inciardi M, O\u2019Neil M, Wagner JL, Shah I, Amin AL, et al. Is axillary imaging for invasive lobular carcinoma accurate in determining clinical node staging? Breast Cancer Res Treat. 2021;185:567\u201372.","journal-title":"Breast Cancer Res Treat."},{"key":"2779_CR16","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1200\/JCO.2013.50.9984","volume":"31","author":"AC Wolff","year":"2013","unstructured":"Wolff AC, Hammond ME, Hicks DG, Dowsett M, McShane LM, Allison KH, et al. Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology\/College of American Pathologists clinical practice guideline update. J Clin Oncol. 2013;31:3997\u20134013.","journal-title":"J Clin Oncol."},{"key":"2779_CR17","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1200\/JCO.2018.77.8738","volume":"36","author":"AC Wolff","year":"2018","unstructured":"Wolff AC, Hammond MEH, Allison KH, Harvey BE, Mangu PB, Bartlett JMS, et al. Human epidermal growth factor Receptor 2 testing in breast cancer: American Society of Clinical Oncology\/College of American Pathologists clinical practice guideline focused update. J Clin Oncol. 2018;36:2105\u201322.","journal-title":"J Clin Oncol."},{"key":"2779_CR18","doi-asserted-by":"crossref","unstructured":"Burstein HJ, Curigliano G, Th\u00fcrlimann B, Weber WP, Poortmans P, Regan MM, et al. Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021. Ann Oncol. 2021;32:1216\u201335.","DOI":"10.1016\/j.annonc.2021.06.023"},{"key":"2779_CR19","doi-asserted-by":"publisher","first-page":"696","DOI":"10.2214\/AJR.12.9036","volume":"200","author":"H Abe","year":"2013","unstructured":"Abe H, Schacht D, Sennett CA, Newstead GM, Schmidt RA. Utility of preoperative ultrasound for predicting pN2 or higher stage axillary lymph node involvement in patients with newly diagnosed breast cancer. AJR Am J Roentgenol. 2013;200:696\u2013702.","journal-title":"AJR Am J Roentgenol."},{"key":"2779_CR20","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.2214\/AJR.10.4414","volume":"195","author":"MB Mainiero","year":"2010","unstructured":"Mainiero MB, Cinelli CM, Koelliker SL, Graves TA, Chung MA. Axillary ultrasound and fine-needle aspiration in the preoperative evaluation of the breast cancer patient: an algorithm based on tumor size and lymph node appearance. AJR Am J Roentgenol. 2010;195:1261\u20137.","journal-title":"AJR Am J Roentgenol."},{"key":"2779_CR21","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1245\/s10434-018-6486-6","volume":"25","author":"AE Giuliano","year":"2018","unstructured":"Giuliano AE, Edge SB, Hortobagyi GN. Eighth Edition of the AJCC Cancer Staging Manual: Breast cancer. Ann Surg Oncol. 2018;25:1783\u20135.","journal-title":"Ann Surg Oncol."},{"key":"2779_CR22","unstructured":"Myers RH. Classical and modern regression with applications 2nd Edition; Pacific Grove: Duxbury\/Thompson Learning Publishing Company; 1990."},{"key":"2779_CR23","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1097\/EDE.0b013e3181c30fb2","volume":"21","author":"EW Steyerberg","year":"2010","unstructured":"Steyerberg EW, Vickers AJ, Cook NR, Gerds T, Gonen M, Obuchowski N, et al. Assessing the performance of prediction models: a framework for traditional and novel measures. Epidemiology. 2010;21:128\u201338.","journal-title":"Epidemiology."},{"key":"2779_CR24","unstructured":"Luque-Fernandez MA, Redondo-Sanchez D, Maringe C. Cross-validated area under the curve. GitHub repository; 2019. https:\/\/github.com\/migariane\/cvaurocAccessed, Accessed 17 Nov\u00a02021"},{"key":"2779_CR25","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1186\/s12957-021-02391-3","volume":"19","author":"IPC Buzatto","year":"2021","unstructured":"Buzatto IPC, Dos Reis FJC, de Andrade JM, Rodrigues TCGF, Borba JMC, Netto AH, et al. Axillary ultrasound and fine-needle aspiration cytology to predict clinically relevant nodal burden in breast cancer patients. World J Surg Oncol. 2021;19:292.","journal-title":"World J Surg Oncol."},{"key":"2779_CR26","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1136\/jcp.2005.029991","volume":"59","author":"G Cserni","year":"2006","unstructured":"Cserni G, Bianchi S, Vezzosi V, Peterse H, Sapino A, Arisio R, et al. The value of cytokeratin immunohistochemistry in the evaluation of axillary sentinel lymph nodes in patients with lobular breast carcinoma. J Clin Pathol. 2006;59:518\u201322.","journal-title":"J Clin Pathol."},{"key":"2779_CR27","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.amjsurg.2007.06.017","volume":"194","author":"JC Boughey","year":"2007","unstructured":"Boughey JC, Middleton LP, Harker L, Garrett B, Fornage B, Hunt KK, et al. Utility of ultrasound and fine-needle aspiration biopsy of the axilla in the assessment of invasive lobular carcinoma of the breast. Am J Surg. 2007;194:450\u20135.","journal-title":"Am J Surg."},{"key":"2779_CR28","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.ejso.2014.03.026","volume":"40","author":"A Topps","year":"2014","unstructured":"Topps A, Clay V, Absar M, Howe M, Lim Y, Johnson R, et al. The sensitivity of pre-operative axillary staging in breast cancer: comparison of invasive lobular and ductal carcinoma. Eur J Surg Oncol. 2014;40:813\u20137.","journal-title":"Eur J Surg Oncol."},{"key":"2779_CR29","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1002\/bjs.10791","volume":"105","author":"E Morrow","year":"2018","unstructured":"Morrow E, Lannigan A, Doughty J, Litherland J, Mansell J, Stallard S, et al. Population-based study of the sensitivity of axillary ultrasound imaging in the preoperative staging of node-positive invasive lobular carcinoma of the breast. Br J Surg. 2018;105:987\u201395.","journal-title":"Br J Surg."},{"key":"2779_CR30","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/cncr.21568","volume":"106","author":"T Kim","year":"2006","unstructured":"Kim T, Giuliano AE, Lyman GH. Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: a metaanalysis. Cancer. 2006;106:4\u201316.","journal-title":"Cancer."},{"key":"2779_CR31","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/S1470-2045(07)70278-4","volume":"8","author":"DN Krag","year":"2007","unstructured":"Krag DN, Anderson SJ, Julian TB, Brown AM, Harlow SP, Ashikaga T, et al. Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial. Lancet Oncol. 2007;8:881\u20138.","journal-title":"Lancet Oncol."},{"key":"2779_CR32","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12957-022-02520-6","volume":"20","author":"ST Chen","year":"2022","unstructured":"Chen ST, Lai HW, Wu WP, Chen ST, Liao CY, Wu HK, et al. The impact of body mass index (BMI) on MRI diagnostic performance and surgical management for axillary lymph node in breast cancer. World J Surg Oncol. 2022;20:45.","journal-title":"World J Surg Oncol."},{"key":"2779_CR33","doi-asserted-by":"publisher","first-page":"3278","DOI":"10.1245\/s10434-014-3902-4","volume":"21","author":"AR Shah","year":"2014","unstructured":"Shah AR, Glazebrook KN, Boughey JC, Hoskin TL, Shah SS, Bergquist JR, et al. Does BMI affect the accuracy of preoperative axillary ultrasound in breast cancer patients? Ann Surg Oncol. 2014;21:3278\u201383.","journal-title":"Ann Surg Oncol."}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-022-02779-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-022-02779-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-022-02779-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,28]],"date-time":"2022-09-28T05:02:49Z","timestamp":1664341369000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-022-02779-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,28]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2779"],"URL":"https:\/\/doi.org\/10.1186\/s12957-022-02779-9","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,28]]},"assertion":[{"value":"11 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The institutional review board and ethical committee of our institution approved this study (approval no. 2017-278). The requirement for informed consent was waived because of the retrospective design of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"314"}}